siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review

Author:

Sargazi Saman1ORCID,Arshad Rabia2,Ghamari Reza3,Rahdar Abbas4,Bakhshi Ali5ORCID,Karkan Sonia Fathi67,Ajalli Narges8,Bilal Muhammad9,Díez‐Pascual Ana M.10ORCID

Affiliation:

1. Cellular and Molecular Research Center Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences Zahedan Iran

2. Department of Pharmacy Quaid‐i‐Azam University Islamabad Islamabad Pakistan

3. Department of Biotechnology National Institute of Genetic Engineering and Biotechnology Tehran Iran

4. Department of Physics University of Zabol Zabol Iran

5. School of Physics Institute for Research in Fundamental Sciences (IPM) Tehran Iran

6. Student Research Committee Tabriz University of Medical Sciences Tabriz Iran

7. Department of Medical Nanotechnology Faculty of Advanced Medical Sciences Tabriz University of Medical Sciences Tabriz Iran

8. Department of Chemical Engineering, Faculty of Engineering University of Tehran Tehran Iran

9. School of Life Science and Food Engineering Huaiyin Institute of Technology Huaian China

10. Universidad de Alcalá, Facultad de Ciencias, Departamento de Quimica Analítica Química Física e Ingeniería Química, Ctra. Madrid‐Barcelona, Alcalá de Henares Madrid Spain

Funder

Comunidad de Madrid

Publisher

Wiley

Subject

Cell Biology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3